Market Closed -
Other stock markets
|
Pre-market 07:58:28 | |||
13.78 USD | -1.89% |
|
13.94 | +1.09% |
06-14 | Novavax Files Emergency Use Authorization Amendment For Updated COVID-19 Vaccine | MT |
06-14 | FDA asks COVID vaccine makers to target KP.2 strain with updated shots | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+187.19% | 1.94B | |
+34.01% | 51.07B | |
+34.69% | 38.61B | |
-8.02% | 38.78B | |
-8.98% | 27.32B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Novavax Says FDA Review Target Date Set for Covid-19 Vaccine Biologics License Application